Search

Your search keyword '"Therriault, Joseph"' showing total 942 results

Search Constraints

Start Over You searched for: "Therriault, Joseph" Remove constraint "Therriault, Joseph"
942 results on '"Therriault, Joseph"'

Search Results

1. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease

2. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

3. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

5. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts

6. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

9. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

10. Biomarker-based staging of Alzheimer disease: rationale and clinical applications

11. CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

13. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

14. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

15. Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging

16. 14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

17. Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

18. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

19. Vascular risk burden is a key player in the early progression of Alzheimer’s disease

20. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

22. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging

25. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

26. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

27. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia

28. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

29. Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging

30. Microglial activation and tau propagate jointly across Braak stages

31. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease

33. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer's disease.

34. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

35. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease.

36. Sex modulates the role of astrocyte reactivity in preclinical Alzheimer’s disease

37. Synaptic dysfunction, Tau pathology and Neurodegeneration

38. Plasma pTau217: single vs multiple phospho‐site assays.

39. CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration

40. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease

41. Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer’s disease continuum

42. Plasma p‐tau and brain‐derived total tau biomarkers predict longitudinal changes in Aβ, tau, and cognition across the AD continuum

43. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease

44. Amyloid β‐dependent tau phosphorylation is triggered by reactive astrocytes in preclinical Alzheimer’s disease

46. Associations and interactions of synaptic and inflammatory biomarkers in Alzheimer's disease

47. Plasma biomarkers as stand‐alone tests in the diagnosis of Alzheimer’s disease

48. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation

49. Interactions of synaptic and inflammatory biomarkers in Alzheimer’s Disease

50. Assessment of brain oxygen extraction in aging and Alzheimer’s disease with MRI images

Catalog

Books, media, physical & digital resources